AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17001471 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 521
Study 17001471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 521
Study 14612477 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (50 mg oral at 24 hours and 1-2 hours before TKA, 50 mg daily for 5 days postoperatively, and 25 mg daily for another 8 days)
Number of subjects: 70
Study 14612477 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 70
Study 14612477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 10469966 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy
Number of subjects: 200
Study 10469966 — intervention group
Group type: COMPARATOR
Intervention: Control (no posterior pericardiotomy)
Number of subjects: 200
Study 9122013 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum TNF-alpha (SeTNF)
Number of subjects: 99
Study 9122013 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary TNF-alpha (UTNF)
Number of subjects: 99
Study 9122013 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum IL-6 (SeIL-6)
Number of subjects: 99
Study 9122013 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary IL-6 (UIL-6)
Number of subjects: 99
Study 9122013 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics therapy
Number of subjects: 99
Study 9122013 — intervention group
Group type: EXPERIMENTAL
Intervention: High urinary levels of IL-6 and/or TNF-alpha
Number of subjects: 99
Study 1812424 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal outer membrane vesicle serogroup B vaccine (MenB‐vaccine "Folkehelsa")
Number of subjects: 221
Study 6615664 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (200 mg twice daily for five days)
Number of subjects: 0
Study 6615664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31326340 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive extensive rotator interval release (group 1)
Number of subjects: 80
Study 31326340 — intervention group
Group type: COMPARATOR
Intervention: RI nonrelease (group 2)
Number of subjects: 80
Study 29116303 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Number of subjects: 0
Study 29116303 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS)
Number of subjects: 0
Study 29116303 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 26345529 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory rehabilitation exercise training (twice a day, 10-30 minutes per session for 4 days)
Number of subjects: 61
Study 26345529 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 61
Study 23532747 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 0
Study 23532747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23532747 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine, Sertraline, Venlafaxine
Number of subjects: 0
Study 21784328 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus individualised homeopathy (HC)
Number of subjects: 39
Study 21784328 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 39
Study 19931760 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-head CPR
Number of subjects: 21
Study 19931760 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 21
Study 16950948 — intervention group
Group type: EXPERIMENTAL
Intervention: Spring dosing schedule of trivalent inactivated influenza vaccine
Number of subjects: 468
Study 16950948 — intervention group
Group type: COMPARATOR
Intervention: Fall dosing schedule of trivalent inactivated influenza vaccine
Number of subjects: 468
Study 15258384 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascovertin
Number of subjects: 31
Study 15258384 — intervention group
Group type: COMPARATOR
Intervention: Control (no Ascovertin)
Number of subjects: 31
Study 11374008 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine (10 mg/day)
Number of subjects: 605
Study 11374008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605
Study 8980210 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical history supplied for the first reading
Number of subjects: 100
Study 8980210 — intervention group
Group type: COMPARATOR
Intervention: Clinical history omitted for the second reading
Number of subjects: 100
Study 8980210 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham history shown to 5 cases
Number of subjects: 100
Study 8077310 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (2 micrograms/kg.min)
Number of subjects: 8
Study 8077310 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study 3608345 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide 2mg orally (as tablets)
Number of subjects: 6
Study 3608345 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide 2mg intravenously
Number of subjects: 6
Study 31900134 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD risk assessment and communication by nurses for primary prevention of CVDs
Number of subjects: 902
Study 31900134 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD risk assessment and communication by nurses for secondary prevention of CVDs
Number of subjects: 902
Study 29371234 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention to improve diet quality over 18 months
Number of subjects: 0
Study 29371234 — intervention group
Group type: EXPERIMENTAL
Intervention: Disordered eating behaviors (DEB)
Number of subjects: 0
Study 26990655 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputation methods
Number of subjects: 0
Study 26990655 — intervention group
Group type: COMPARATOR
Intervention: Complete case analysis
Number of subjects: 0
Study 26990655 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-effects multiple imputation
Number of subjects: 0
Study 26990655 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-level multiple imputation
Number of subjects: 0
Study 26990655 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel multiple imputation
Number of subjects: 0
Study 25621429 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocodone (HC)
Number of subjects: 0
Study 23605377 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Windshield Tours
Number of subjects: 0
Study 23605377 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-/post-tour surveys
Number of subjects: 0
Study 23605377 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up surveys
Number of subjects: 0
Study 23605377 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH activities
Number of subjects: 0
Study 20195575 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 30
Study 20195575 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA)
Number of subjects: 30
Study 20195575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 19368098 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycaemic control
Number of subjects: 0
Study 19368098 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification plus combinations of insulin sensitisers and insulin secretagogues
Number of subjects: 0
Study 19368098 — intervention group
Group type: EXPERIMENTAL
Intervention: Incretin mimetics or insulin
Number of subjects: 0
Study 16736339 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage (IBS) with transfusion of both allogeneic and autologous blood
Number of subjects: 44
Study 16736339 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic blood transfusion at the discretion of the attending medical staff
Number of subjects: 44
Study 16736339 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage (IBS)
Number of subjects: 44
Study 16736339 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic blood transfusion
Number of subjects: 44
Study 12669748 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual reaching movements with targets of the same color
Number of subjects: 0
Study 12669748 — intervention group
Group type: COMPARATOR
Intervention: Bimanual reaching movements with targets of different colors
Number of subjects: 0
Study 12669748 — intervention group
Group type: EXPERIMENTAL
Intervention: Unimanual movements presented among distractors associated with responses for the other hand
Number of subjects: 0
Study 10809299 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH)
Number of subjects: 6
Study 10809299 — intervention group
Group type: COMPARATOR
Intervention: Continuous venovenous hemodiafiltration (CVVHD)
Number of subjects: 6
Study 10809299 — intervention group
Group type: EXPERIMENTAL
Intervention: CVVH
Number of subjects: 6
Study 10809299 — intervention group
Group type: COMPARATOR
Intervention: CVVHD
Number of subjects: 6
Study 8857005 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injections of hCG (250, 500, 1000, or 2000 IU) three times a week for two weeks.
Number of subjects: 36
Study 8857005 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injections of 2000 IU of hCG.
Number of subjects: 36
Study 8857005 — intervention group
Group type: COMPARATOR
Intervention: Diluent alone (control group).
Number of subjects: 36
Study 8857005 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injections of hCG.
Number of subjects: 36
Study 1350495 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 20
Study 1350495 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzhexol (5 mg)
Number of subjects: 20
Study 1350495 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (1 mg)
Number of subjects: 20
Study 1350495 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg)
Number of subjects: 20
Study 1350495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6368614 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg propiram fumarate
Number of subjects: 159
Study 6368614 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 mg aspirin
Number of subjects: 159
Study 6368614 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg codeine phosphate
Number of subjects: 159
Study 6368614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 30381313 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent m-Health behaviour change weight loss intervention
Number of subjects: 0
Study 30381313 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced intervention (physical activity, dietary behaviour and sleep intervention)
Number of subjects: 0
Study 30381313 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional intervention (physical activity and dietary behaviour only)
Number of subjects: 0
Study 30381313 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 26564024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 3883
Study 26564024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3883
Study 24995191 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol and Ketamine (PK)
Number of subjects: 60
Study 24995191 — intervention group
Group type: COMPARATOR
Intervention: Propofol and Fentanyl (PF)
Number of subjects: 60
Study 23318236 — intervention group
Group type: EXPERIMENTAL
Intervention: Eco-friendly vector control programme
Number of subjects: 0
Study 23318236 — intervention group
Group type: COMPARATOR
Intervention: Control clusters
Number of subjects: 0
Study 20117554 — intervention group
Group type: COMPARATOR
Intervention: 2-year ecologic intervention to prevent weight gain through changes in worksite weight-related norms.
Number of subjects: 806
Study 20117554 — intervention group
Group type: COMPARATOR
Intervention: Intervention participation (scale=0 to 100) as independent variable.
Number of subjects: 806
Study 20117554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention sites
Number of subjects: 806
Study 20117554 — intervention group
Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 806
Study 17013567 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 mcg/day
Number of subjects: 0
Study 17013567 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 40 mcg/day
Number of subjects: 0
Study 17013567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17013567 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (20 or 40 mcg/day)
Number of subjects: 0
Study 17013567 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (40 mcg/day)
Number of subjects: 0
Study 15823826 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) 0.625 mg/day
Number of subjects: 30
Study 15823826 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) 0.625 mg/day plus medroxyprogesterone acetate (MPA) 2.5 mg/day
Number of subjects: 30
Study 15823826 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 5.0 mg/day
Number of subjects: 30
Study 11990920 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasojejunal feeding (34 patients)
Number of subjects: 73
Study 11990920 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric feeding (39 patients)
Number of subjects: 73
Study 10064759 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy (prophylactic)
Number of subjects: 80
Study 10064759 — intervention group
Group type: COMPARATOR
Intervention: Control (no chest physiotherapy)
Number of subjects: 80
Study 7472662 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic acid supplementation (10 g/d from the 20th week of gestation until delivery)
Number of subjects: 21
Study 7472662 — intervention group
Group type: COMPARATOR
Intervention: LL-control group (n = 22)
Number of subjects: 21
Study 7472662 — intervention group
Group type: COMPARATOR
Intervention: HL-control group (n = 21)
Number of subjects: 21
Study 7472662 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic acid supplementation
Number of subjects: 21
Study 7472662 — intervention group
Group type: COMPARATOR
Intervention: LL-control group
Number of subjects: 21
Study 2318517 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose hydrochlorothiazide (25-50 mg)
Number of subjects: 690
Study 2318517 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose hydrochlorothiazide (50-100 mg)
Number of subjects: 690
Study 2318517 — intervention group
Group type: COMPARATOR
Intervention: Second drug (hydralazine, methyldopa, metoprolol, or reserpine) added to hydrochlorothiazide
Number of subjects: 690
Study 380412 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbuterol 3 mg
Number of subjects: 21
Study 380412 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 4 mg
Number of subjects: 21
Study 29122360 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment involving 7 or more beams
Number of subjects: 709
Study 29122360 — intervention group
Group type: EXPERIMENTAL
Intervention: More rigorous dose calculation algorithm
Number of subjects: 709
Study 29122360 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 or more beams and rigorous dose calculation
Number of subjects: 709
Study 27921088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra uterine extra-amniotic misoprostol (200 µg every 4 hrs)
Number of subjects: 180
Study 27921088 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (200 µg every 4 hrs)
Number of subjects: 180
Study 24713049 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate variability (HRV) measures during SBT
Number of subjects: 434
Study 24713049 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory rate variability (RRV) measures during SBT
Number of subjects: 434
Study 24713049 — intervention group
Group type: EXPERIMENTAL
Intervention: WAVE score (derived from RRV during SBT)
Number of subjects: 434
Study 23694801 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg intravenous hydromorphone bolus
Number of subjects: 334
Study 23694801 — intervention group
Group type: COMPARATOR
Intervention: 1+1 hydromorphone titration protocol
Number of subjects: 334
Study 20162528 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume hemofiltration (HVHF) treatment for 72 hours initiated within 2 hours after enrollment
Number of subjects: 12
Study 20162528 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 12
Study 18219179 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia patients
Number of subjects: 281
Study 16884466 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 4 microg x kg(‐1) approximately 100 min before anesthesia
Number of subjects: 56
Study 16884466 — intervention group
Group type: COMPARATOR
Intervention: Control (no clonidine premedication)
Number of subjects: 56
Study 11391125 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 7
Study 11391125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 9886725 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 292
Study 9886725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study 8276647 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose rate brachytherapy
Number of subjects: 482
Study 8276647 — intervention group
Group type: COMPARATOR
Intervention: High dose rate brachytherapy
Number of subjects: 482
Study 2788919 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 80
Study 2788919 — intervention group
Group type: COMPARATOR
Intervention: Conventional local anaesthesia
Number of subjects: 80
Study 17233164 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine rinse
Number of subjects: 45
Study 17233164 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse
Number of subjects: 45
Study 17233164 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 45
Study 656283 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine treatment (about 4 g three times daily)
Number of subjects: 5
Study 31171492 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports/exercise
Number of subjects: 0
Study 31171492 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous intensity PA
Number of subjects: 0
Study 27548839 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong/tai chi (QGTC)
Number of subjects: 90
Study 27548839 — intervention group
Group type: EXPERIMENTAL
Intervention: Light exercise (LE)
Number of subjects: 90
Study 27548839 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WL)
Number of subjects: 90
Study 26025798 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 90
Study 26025798 — intervention group
Group type: COMPARATOR
Intervention: Rest without treatment (Control)
Number of subjects: 90
Study 24491267 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy plus 3,500 IU daily of bemiparin for a maximum of 26 weeks
Number of subjects: 38
Study 24491267 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy alone
Number of subjects: 38
Study 24491267 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 24491267 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemiparin
Number of subjects: 38
Study 22157768 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐IFN alfa‐2a with ribavirin
Number of subjects: 260
Study 22157768 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐IFN alfa‐2b with ribavirin
Number of subjects: 260
Study 22157768 — intervention group
Group type: COMPARATOR
Intervention: Peg‐IFN alfa‐2a or Peg‐IFN alfa‐2b with ribavirin
Number of subjects: 260
Study 19303163 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 213
Study 19303163 — intervention group
Group type: EXPERIMENTAL
Intervention: HVPG >10 mmHg
Number of subjects: 213
Study 19303163 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 213
Study 19303163 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral etiology
Number of subjects: 213
Study 19303163 — intervention group
Group type: EXPERIMENTAL
Intervention: HVPG
Number of subjects: 213
Study 17523385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Betulaceae extracts
Number of subjects: 47
Study 17523385 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy (SCIT) with Betulaceae extracts
Number of subjects: 47
Study 15453520 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) over left motor cortex at 110% of motor threshold, using 1 Hz or 15 Hz stimulation.
Number of subjects: 8
Study 15453520 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) over left prefrontal cortex at 110% of motor threshold, using 1 Hz or 15 Hz stimulation.
Number of subjects: 8
Study 15453520 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial magnetic stimulation.
Number of subjects: 8
Study 12704887 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic J-pouch reconstruction
Number of subjects: 0
Study 12704887 — intervention group
Group type: COMPARATOR
Intervention: Alternative methods (ileocecal reservoir, transverse coloplasty pouch, side-to-end anastomosis)
Number of subjects: 0
Study 9657238 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate 2 g daily for 7 days
Number of subjects: 12
Study 9657238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7660440 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose of mefloquine (750 mg at 24 h)
Number of subjects: 57
Study 7660440 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of mefloquine (750 mg at 24 h, then 500 mg at 30 h)
Number of subjects: 57
Study 2757880 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 60 mg twice daily for 28 days
Number of subjects: 14
Study 2757880 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 767091 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily thorough cleaning of dentures
Number of subjects: 0